Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Spinal Cord Neoplasms 1Pituitary Neoplasms 1Parkinson Disease 1Nervous System Diseases 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Hematologic Diseases 1Epilepsy 1Brain Neoplasms 1Bone Marrow Diseases 1

Interventions

Radiosurgery 28Magnetic Resonance Spectroscopy 15Temozolomide 14pembrolizumab 13Bevacizumab 11Nivolumab 10Ipilimumab 8Memantine 7Specimen Handling 6Radiotherapy 6Mental Status and Dementia Tests 6abemaciclib 5Blood Specimen Collection 5Radiation 4trastuzumab deruxtecan 3entrectinib 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Sodium Chloride 3Saline Solution 3Receptors, Interleukin-8B 3Proton Therapy 3Biopsy 3trametinib 2pertuzumab 2osimertinib 2lenvatinib 2fluciclovine F-18 2contrast agent BR1 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Clinical Laboratory Techniques × 90 days × Clear all
NCT00060541 2026-06-01

Evaluation and Treatment of Neurosurgical Disorders

National Institutes of Health Clinical Center (CC)

Recruiting
5,000 enrolled
CNSEndocrine

Brain Neoplasms, Epilepsy, Nervous System Diseases, Parkinson Disease, Pituitary Neoplasms, Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡